Esperemos que desde Zeltia nos expliquen el potencial de dicho ensayo recien iniciado por J&J .....
Study Type: Interventional
Study Design: Treatment, Non-Randomized, Single Blind, Single Group Assignment, Safety Study
Official Title: A Single-Blind, Multicenter, Placebo-Controlled, Sequential Design Study Evaluating the Potential Effects of a Single-Dose Administration of Trabectedin on the QT Intervals of the Electrocardiogram
Further study details as provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.:
Primary Outcome Measures:
The purpose of the study is to determine the effects of trabectedin on the heart's electrical cycle as measured by electrocardiograms (ECGs) in patients with advanced cancer.
Secondary Outcome Measures:
Assess the safety and pharmacokinetics of trabectedin.